Martínez-Ramírez Imelda, Del-Castillo-Falconi Víctor, Mitre-Aguilar Irma B, Amador-Molina Alfredo, Carrillo-García Adela, Langley Elizabeth, Zentella-Dehesa Alejandro, Soto-Reyes Ernesto, García-Carrancá Alejandro, Herrera Luis A, Lizano Marcela
Unidad de Investigación Biomédica en Cáncer, Instituto Nacional de Cancerología (INCan)/Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 14080, Mexico.
Unidad de Bioquímica, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ)/Unidad Periférica del Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), Ciudad de México 14080, Mexico.
Viruses. 2017 Jul 5;9(7):175. doi: 10.3390/v9070175.
Persistent infections with high-risk human papillomavirus (HPV) constitute the main risk factor for cervical cancer development. HPV16 is the most frequent type associated to squamous cell carcinomas (SCC), followed by HPV18. The long control region (LCR) in the HPV genome contains the replication origin and sequences recognized by cellular transcription factors (TFs) controlling viral transcription. Altered expression of and viral oncogenes, modulated by the LCR, causes modifications in cellular pathways such as proliferation, leading to malignant transformation. The aim of this study was to identify specific TFs that could contribute to the modulation of high-risk HPV transcriptional activity, related to the cellular histological origin. We identified sex determining region Y (SRY)-box 2 (SOX2) response elements present in HPV16-LCR. SOX2 binding to the LCR was demonstrated by in vivo and in vitro assays. The overexpression of this TF repressed HPV16-LCR transcriptional activity, as shown through reporter plasmid assays and by the down-regulation of endogenous HPV oncogenes. Site-directed mutagenesis revealed that three putative SOX2 binding sites are involved in the repression of the LCR activity. We propose that SOX2 acts as a transcriptional repressor of HPV16-LCR, decreasing the expression of and oncogenes in a SCC context.
高危型人乳头瘤病毒(HPV)的持续感染是宫颈癌发生的主要危险因素。HPV16是与鳞状细胞癌(SCC)相关的最常见类型,其次是HPV18。HPV基因组中的长控制区(LCR)包含复制起点以及由控制病毒转录的细胞转录因子(TFs)识别的序列。由LCR调节的病毒癌基因的表达改变会导致细胞途径(如增殖)的改变,从而导致恶性转化。本研究的目的是确定特定的转录因子,这些转录因子可能有助于调节与细胞组织学起源相关的高危型HPV转录活性。我们在HPV16-LCR中鉴定出性别决定区Y(SRY)-盒2(SOX2)反应元件。通过体内和体外试验证实了SOX2与LCR的结合。如报告质粒试验和内源性HPV癌基因的下调所示,该转录因子的过表达抑制了HPV16-LCR的转录活性。定点诱变表明,三个假定的SOX2结合位点参与了LCR活性的抑制。我们提出,SOX2作为HPV16-LCR的转录抑制因子,在SCC背景下降低了癌基因的表达。